C5a stimulation induces caspase-1 activation and mature IL-1β production in human peripheral blood mononuclear cells

References

• Merle NS, Noe R, Halbwachs-Mecarelli L, et al. Complement system part II: role in immunity. Front Immunol. 2015;6:257. doi: 10.3389/fimmu.2015.00257.
   PubMed Web of Science ®Google Scholar
• Ballanti E, Perricone C, Greco E, et al. Complement and autoimmunity. Immunol Res. 2013;56(2–3):477–491. doi: 10.1007/s12026-013-8422-y.
   PubMed Web of Science ®Google Scholar
• Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun. 2010;34(3):J276–J286. doi: 10.1016/j.jaut.2009.11.014.
   PubMed Web of Science ®Google Scholar
• Holers VM. Complement and its receptors: new insights into human disease. Annu Rev Immunol. 2014;32(1):433–459. doi: 10.1146/annurev-immunol-032713-120154.
   PubMed Web of Science ®Google Scholar
• Walport MJ. Complement. N Engl J Med. 2001;344(15):1140–1144. doi: 10.1056/NEJM200104123441506.
   PubMed Web of Science ®Google Scholar
• Wood AJ, Vassallo A, Summers C, et al. C5a anaphylatoxin and its role in critical illness-induced organ dysfunction. Eur J Clin Invest. 2018;48(12):e13028.
   PubMed Web of Science ®Google Scholar
• Horiuchi T, Tsukamoto H. Complement-targeted therapy: development of C5- and C5a-targeted inhibition. Inflamm Regen. 2016;36(1):11.
   PubMedGoogle Scholar
• Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20(23):6008. doi: 10.3390/ijms20236008.
   PubMed Web of Science ®Google Scholar
• Chung Y, Chang SH, Martinez GJ, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity. 2009;30(4):576–587. doi: 10.1016/j.immuni.2009.02.007.
   PubMed Web of Science ®Google Scholar
• Netea MG, Simon A, van de Veerdonk F, et al. IL-1β processing in host defense: beyond the inflammasomes. PLoS Pathog. 2010;6(2):e1000661. doi: 10.1371/journal.ppat.1000661.
   PubMed Web of Science ®Google Scholar
• Gabay C, Lamacchia C, Palmer G. IL-1 pathways in inflammation and human diseases. Nat Rev Rheumatol. 2010;6(4):232–241. doi: 10.1038/nrrheum.2010.4.
   PubMed Web of Science ®Google Scholar
• Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20(13):3328. doi: 10.3390/ijms20133328.
   PubMed Web of Science ®Google Scholar
• Grabarek J, Darzynkiewicz Z. In situ activation of caspases and serine proteases during apoptosis detected by affinity labeling their enzyme active centers with fluorochrome-tagged inhibitors. Exp Hematol. 2002;30(9):982–989. doi: 10.1016/s0301-472x(02)00886-x.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, et al. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11(9):785–797. doi: 10.1038/ni.1923.
   PubMed Web of Science ®Google Scholar
• Bacle F, Haeffner-Cavaillon N, Laude M, et al. Induction of IL-1 release through stimulation of the C3b/C4b complement receptor type one (CR1, CD35) on human monocytes. J Immunol. 1990;144(1):147–152. doi: 10.4049/jimmunol.144.1.147.
   PubMed Web of Science ®Google Scholar
• Haeffner-Cavaillon N, Cavaillon JM, Laude M, et al. C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes. J Immunol. 1987;139(3):794–799. doi: 10.4049/jimmunol.139.3.794.
   PubMed Web of Science ®Google Scholar
• Colley CS, Popovic B, Sridharan S, et al. Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors. MAbs. 2018;10(1):104–117. doi: 10.1080/19420862.2017.1384892.
   PubMed Web of Science ®Google Scholar
• Hoffman HM, Wanderer AA. Inflammasome and IL-1β-mediated disorders. Curr Allergy Asthma Rep. 2010;10(4):229–235. doi: 10.1007/s11882-010-0109-z.
   PubMed Web of Science ®Google Scholar
• Sims JE, Smith DE. The IL-1 family: regulators of immunity. Nat Rev Immunol. 2010;10(2):89–102. doi: 10.1038/nri2691.
   PubMed Web of Science ®Google Scholar
• Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol. 2011;41(5):1203–1217. doi: 10.1002/eji.201141550.
   PubMed Web of Science ®Google Scholar
• Martinon F, Burns K, Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell. 2002;10(2):417–426. doi: 10.1016/s1097-2765(02)00599-3.
   PubMed Web of Science ®Google Scholar
• Cavaillon J-M, Fitting C, Haeffner-Cavaillon N. Recombinant C5a enhances interleukin 1 and tumor necrosis factor release by lipopolysaccharide-stimulated monocytes and macrophages. Eur J Immunol. 1990;20(2):253–257. doi: 10.1002/eji.1830200204.
   PubMed Web of Science ®Google Scholar
• Morin M, Schindler R, Wakabayashi G, et al. Picogram concentrations of endotoxin stimulate synthesis of IL-1 beta and TNF alpha by human peripheral blood mononuclear cells exposed to recombinant human C5a. Eur Cytok Netw. 1991;2(1):27–30.
   PubMedGoogle Scholar
• An L-L, Mehta P, Xu L, et al. Complement C5a potentiates uric acid crystal-induced IL-1β production. Eur J Immunol. 2014;44(12):3669–3679. doi: 10.1002/eji.201444560.
   PubMed Web of Science ®Google Scholar
• Soruri A, Riggert J, Schlott T, et al. Anaphylatoxin C5a induces monocyte recruitment and differentiation into dendritic cells by TNF-α and prostaglandin E2-dependent mechanisms. J Immunol. 2003;171(5):2631–2636. doi: 10.4049/jimmunol.171.5.2631.
   PubMed Web of Science ®Google Scholar
• Laudisi F, Spreafico R, Evrard M, et al. Cutting edge: the NLRP3 inflammasome links complement-mediated inflammation and IL-1β release. J Immunol. 2013;191(3):1006–1010. doi: 10.4049/jimmunol.1300489.
   PubMed Web of Science ®Google Scholar
• Miller AM, Stella N. Microglial cell migration stimulated by ATP and C5a involve distinct molecular mechanisms: quantification of migration by a novel near-infrared method. Glia. 2009;57(8):875–883. doi: 10.1002/glia.20813.
   PubMed Web of Science ®Google Scholar
• Li XX, Lee JD, Kemper C, et al. The complement receptor C5aR2: a powerful modulator of innate and adaptive immunity. J Immunol. 2019;202(12):3339–3348. doi: 10.4049/jimmunol.1900371.
   PubMed Web of Science ®Google Scholar
• Zhang T, Garstka MA, Li K. The controversial C5a receptor C5aR2: its role in health and disease. J Immunol Res. 2017;2017:8193932. doi: 10.1155/2017/8193932.
   PubMed Web of Science ®Google Scholar
• Haggadone MD, Grailer JJ, Fattahi F, et al. Bidirectional crosstalk between C5a receptors and the NLRP3 inflammasome in macrophages and monocytes. Mediators Inflamm. 2016;2016:1340156. doi: 10.1155/2016/1340156.
   PubMed Web of Science ®Google Scholar